Skip to main content

Clinical Trial Workflow and Data Integration

This page describes the end-to-end workflow for acne severity assessment in a clinical trial using the Legit.Health platform, from protocol design through to EDC data delivery.

Workflow overview

The clinical trial workflow consists of eight stages:

  1. Protocol design: Configure the study with Legit.Health
  2. Site setup: Deploy the platform to investigator sites
  3. Patient enrollment: Register patients in the platform
  4. Image capture: Guided smartphone photography at the site
  5. AI scoring: Automated endpoint calculation
  6. Report review: Investigator reviews the severity report
  7. Severity tracking: Longitudinal score monitoring
  8. Data export: Structured delivery to EDC systems

1. Protocol design

Before the study begins, Legit.Health works with the sponsor or CRO to configure the study protocol:

Configuration itemOptionsExample
Imaging perspectives2-perspective diagonal, 3-perspective perpendicular, custom2 perspectives (Hayashi Criterion)
EndpointsLesion count, density, IGA, ALADIN (any combination)Lesion count + IGA (co-primary) + density (exploratory)
Global aggregationMaximum, sum, or mean of local scoresMaximum (default)
DIQA thresholdStrict (pivotal) or lenient (RWE)Strict for Phase III
Data export formatAPI, CSV, CRF-mapped fieldsCRF-mapped to sponsor’s EDC

A study-specific investigator manual is generated for each trial, providing site personnel with step-by-step instructions, example images, and a knowledge test to confirm training.

2. Site setup

The Legit.Health clinical trials platform is deployed as a web application accessible from any browser. Each investigator site receives:

  • Login credentials for all study personnel
  • Pre-configured protocol (perspectives, endpoints, scoring method)
  • Investigator manual (digital, accessible from the platform)
  • Training resources and knowledge test

No hardware installation is required; investigators use their existing smartphones for image capture.

3. Patient enrollment

After enrolling a patient in the study per the clinical protocol, the investigator creates the patient record in the Legit.Health platform:

Add new

Select the body area(s)

Select the most common

Do you want to track this condition?

Add condition

Each patient is identified by a study-specific pseudonymised identifier; no personal data (name, date of birth) is stored in the platform.

4. Image capture

The investigator captures photographs of the patient's face using the Legit.Health mobile application:

The application provides:

  • Perspective guidance: Visual silhouettes showing the required capture angle for each perspective
  • Real-time DIQA quality check: The image is evaluated for focus, lighting, framing, and resolution immediately after capture
  • Immediate feedback: If the image fails quality standards, the investigator is prompted to recapture with specific guidance
  • Confirmation: Once all perspectives pass quality checks, the images are submitted for AI processing

For the standard 2-perspective protocol, the entire capture process takes approximately 30–60 seconds.

5. AI scoring

Once images are submitted, the AI processes them automatically. Processing takes approximately ~1.2 seconds for 2 images combined. The system produces:

  • Per-lesion bounding box detection (inflammatory lesions: papules, pustules, nodules)
  • Lesion count (NN) per perspective
  • Spatial density (DD) per perspective
  • IGA score per perspective (local) and global
  • ALADIN composite score per perspective (local) and global
  • DIQA quality score per image

Acne Lesion And Density INdex

Score: 3.5

Report Information

Timestamp

3/24/2026, 2:16:00 AM

Analysis performed in

1.2 seconds

Status

Not reviewed

Analyzed Left diagonal

Body site

Left diagonal

p]:mb-0>

Image quality

92%

p]:mb-0>

Lesion count

36

p]:mb-0>

Density

0.55

p]:mb-0>

Local score

3.42

Analyzed Right diagonal

Body site

Right diagonal

p]:mb-0>

Image quality

88%

p]:mb-0>

Lesion count

35

p]:mb-0>

Density

0.6

p]:mb-0>

Local score

3.49

The report is immediately available for the investigator to review.

6. Report review

The investigator reviews the severity report directly in the platform. The report includes:

  • Global scores: IGA (0–4) and ALADIN (0–10), with severity classification
  • Per-perspective breakdown: Lesion count, density, and local scores for each perspective, with annotated images showing bounding boxes around detected lesions
  • Image quality: DIQA score for each captured image

The investigator can verify that the AI's detections align with their clinical observation. If the images are inadequate, the investigator can recapture and resubmit; only the latest submission for each visit is retained.

7. Severity tracking

For follow-up visits, the platform tracks severity evolution across all assessments for the patient:

Severity chart

This longitudinal view enables:

  • Visual comparison of scores over time
  • Treatment response identification: clear trends in score improvement or worsening
  • Protocol adherence monitoring: verify that assessments are captured at the correct visit intervals
  • Automated charting of the severity trajectory for clinical review

8. Data export and EDC integration

Assessment results are structured for integration with the sponsor's EDC (Electronic Data Capture) system.

Exported data fields

FieldDescriptionFormat
Patient identifierStudy-specific pseudonymised IDString
Visit dateDate and timestamp of the assessmentISO 8601
Global IGA scoreIGA severity (0–4)Integer
Global ALADIN scoreComposite severity (0–10)Float
Global lesion countTotal inflammatory lesions (deduplicated across perspectives)Integer
Per-perspective IGALocal IGA score for each perspectiveInteger
Per-perspective lesion countLesions detected per perspectiveInteger
Per-perspective densitySpatial density per perspectiveFloat (0–1)
DIQA scoresImage quality score per perspectiveFloat
Severity classificationClear / Almost clear / Mild / Moderate / SevereString

Integration methods

  • API-based: Automated data flow from the Legit.Health platform to the sponsor’s EDC system via RESTful API
  • CSV export: Structured CSV files for manual import into EDC systems
  • CRF field mapping: Data fields pre-mapped to the sponsor’s Case Report Form structure, configured during protocol design
  • QuantifiCare platform integration: For studies using the combined QuantifiCare + Legit.Health solution, scoring data flows through QuantifiCare’s platform to the sponsor’s data management system

All exported data is structured for direct mapping to CRF fields in standard EDC systems (Medidata Rave, Veeva Vault CDMS, Oracle InForm, etc.).

The integration is API-based and system-agnostic; it works with any EDC system (Medidata Rave, Oracle InForm, Veeva Vault EDC, and others). Export formats include RESTful API, CSV/Excel, and structured JSON. Legit.Health provides IQ/OQ validation documentation and data mapping specifications to support the sponsor's integration validation activities.

Decentralised and hybrid trial support

Hybrid designs

Some study designs combine investigator-captured and patient-captured images:

  • Investigator timepoints: Primary visits (e.g., baseline, month 3, month 6, month 12) where images are captured by trained site personnel at the clinic
  • Patient timepoints: Intermediate visits (e.g., monthly check-ins) where the patient captures images at home using the mobile application

The same AI scoring pipeline processes both types of images. DIQA quality control is applied identically, ensuring that patient-captured images meet the same quality standards as investigator-captured images.

Remote patient capture

For fully decentralised protocols:

  • Patients download the Legit.Health mobile application
  • The app guides them through the capture process with the same perspective silhouettes and DIQA quality checks used at investigator sites
  • Captured images are transmitted securely to the platform for AI scoring
  • The investigator can review scores remotely

Benefits for sponsors

  • Reduced site burden: Fewer in-clinic visits needed for severity assessment
  • Increased data frequency: More timepoints without increasing site workload
  • Patient convenience: Assessments from home reduce travel burden
  • Continuous monitoring: More frequent assessments enable finer-grained treatment response detection